
Bird flu could be heading north this spring with fewer federal health officials working to stop it
At the same time, the United States will have fewer people leading the national effort to stop avian influenza.
The sweeping cuts this week to the federal Department of Health and Human Services include the Food and Drug Administration's chief medical officer, who was helping to lead the federal government's bird flu response, and senior staff from the FDA's Center for Veterinary Medicine, which linked bird flu cases to raw pet food, leading to several recalls.
'We no longer are going to have the same eyes on this virus,' said Dr. Meghan Davis, a former dairy veterinarian and associate professor at the Johns Hopkins Bloomberg School of Public Health. She said active surveillance of and investigation into how the virus spreads are a necessity, but local health officials and veterinarians will no longer have the same support from the federal government.
The ongoing outbreak of bird flu — the worst in U.S. history — picked up steam through the fall and winter, pushing egg prices to record highs. While outbreaks in both poultry and cattle have fallen, along with the average price of eggs, health experts say that cases could rise again amid the spring migration, which typically peaks in May and June in the continental U.S.
Quantifying the scope of bird flu in the U.S. is complicated. The number of confirmed outbreaks in poultry fell to 53 flocks last month after reaching 133 flocks in January. Outbreaks in cattle fell to 21 herds last month, after peaking at 253 in November. Detections in other mammals, wild birds and humans are tracked separately. And the 168 million domestic birds affected so far include many slaughtered because any detection on a poultry farm requires culling all the birds on the premises.
The current outbreak has also been notoriously difficult to predict and contain, jumping to cattle for the first time last year and spreading to other species. Limited data on cases and testing has made it even harder to track the virus's spread and evolution, experts said, which could mean the virus could surge and new variants could emerge with little warning.
'We cannot let our guard down — now is not the time to do that,' said Stacey Schultz-Cherry, an influenza researcher at St. Jude's Children's Research Hospital.
Wild birds are a major pathway for the virus when they land and mingle with domestic animals. Schultz-Cherry warned that the birds currently migrating northward might introduce new variants of the virus from South America to the U.S., giving the virus more opportunities to evolve in potentially dangerous ways. 'That's what we worry about — is this something new?'
Variants of concern have already been emerging. In March, the U.S. confirmed the detection of a bird flu variant known as H7N9 on a Mississippi poultry farm. It was the first time since 2017 that the strain — which is especially deadly to humans — had been detected in a commercial U.S. poultry flock. In January, another variant linked to a handful of severe and fatal human infections was found in U.S. cattle for the first time.
This week, more than 140 staff members from the FDA's Center for Veterinary Medicine, which oversees animal food and medicine, were among the roughly 10,000 staff terminated from the Department of Health and Human Services, according to Alex Saint, who was an FDA communications specialist until she, too, was terminated. The cuts are part of the Trump administration's broader effort to shrink the federal government.
The FDA has become increasingly involved in the bird flu response as the virus has spread beyond birds. More than 120 domestic cats have been infected with bird flu since 2022, according to the U.S. Agriculture Department, and FDA staff helped link some of the cases to raw pet food.
The agency also helped to develop better diagnostic tests for the virus and has conducted extensive bird flu studies showing that pasteurization effectively inactivated the virus, making milk products safe for consumption.
Already, the staff cuts prompted the FDA to suspend an effort to improve testing of pet food and dairy products for bird flu, according to a person familiar with the matter who was not authorized to speak to the media and who spoke to NBC News on the condition of anonymity.
'It's nothing short of devastating to veterinary medicine,' said Dr. K. Fred Gingrich II, executive director of the American Association of Bovine Practitioners, which represents cow veterinarians. 'They were absolutely critical — not just for the bird flu response, but for developing protocols for research and drug development.'
The Department of Health and Human Services said in a statement that the cuts were limited to administrative staff and intended 'to make the agency more efficient and responsive.'
'The FDA and HHS continue to prioritize public health and animal health, including ongoing efforts to monitor and respond" to bird flu, the agency added.
The risk remains low to the public, with 70 confirmed human cases in the U.S. and one death. But the unchecked spread of bird flu increases the chances that the virus could mutate into a strain that is far more deadly to humans and easily transmissible among them.
Experts warn that the broader Department of Health and Human Services cuts also could hamper the country's ability to track and contain the virus among both humans and animals, particularly when outbreaks spread across state lines.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
an hour ago
- Reuters
US FDA extends review of Bayer's menopause relief drug
July 25 (Reuters) - The U.S. Food and Drug Administration has extended its review of Bayer's ( opens new tab experimental menopause relief drug, the German drugmaker said on Friday. The non-hormonal treatment, elinzanetant, is being reviewed for relieving moderate to severe vasomotor symptoms, also known as hot flashes, associated with menopause. The FDA has extended the review by up to 90 days and did not raise any concern regarding the general approvability of the drug, Bayer said. The drug, branded as Lynkuet, is approved in the United Kingdom and Canada.


Reuters
an hour ago
- Reuters
US FDA says J&J's unit issues correction related to surgical stapler
July 25 (Reuters) - The U.S. drug regulator said on Friday a unit of Johnson & Johnson (JNJ.N), opens new tab issued a correction for certain lots of a part related to its surgical stapler and classified the action as "most serious". The issue is related to the unit Ethicon Endo-Surgery's device, 'Endopath Echelon Vascular White Reload for Advanced Placement Tip', which tends to inadvertently lockout during surgical procedures, the Food and Drug Administration said, opens new tab on its website. "There has been one reported death and one injury related to this issue," the agency added. The part in question is a single-use cartridge that surgeons load into a stapler to cut and close blood vessels or tissue during an operation. This helps control bleeding and close wounds quickly. However, the FDA said the device may sometimes appear to work but fail to cut or staple tissue during surgery, and could lead to life-threatening bleeding, surgical delays, or death. A J&J spokesperson said in an email to Reuters that it notified its affected customers through a correction letter in April, and added that it was a voluntary correction, not a product removal. Ethicon has advised healthcare facilities to review affected batches and ensure operating room personnel are familiar with the device's instructions for use and lockout mitigation protocols, the FDA said.


Reuters
2 hours ago
- Reuters
US FDA says J&J's Ethicon issues correction related to surgical stapler
July 25 (Reuters) - The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson (JNJ.N), opens new tab, issued a correction for certain lots of a part related to its surgical stapler and classified the action as "most serious". The issue is related to the device 'Endopath Echelon Vascular White Reload for Advanced Placement Tip' which tends to inadvertently lockout during surgical procedures, the Food and Drug Administration said, opens new tab on its website. "There has been one reported death and one injury related to this issue," the agency added. The part in question is a single-use cartridge that surgeons load into a stapler to cut and close blood vessels or tissue during an operation. This helps control bleeding and close wounds quickly. However, the FDA said the device may sometimes appear to work but fail to cut or staple tissue during surgery, and could lead to life-threatening bleeding, surgical delays, or death. Ethicon notified its affected customers through a correction letter in April, but the company's action is not a full product recall, the agency said. The FDA said Ethicon has advised healthcare facilities to review affected batches and ensure operating room personnel are familiar with the device's instructions for use and lockout mitigation protocols. Johnson & Johnson did not immediately respond to a Reuters request for comment.